Japan’s Otsuka Pharmaceutical to pay $800-million to Jnana Therapeutics shareholders along with up to $325-million in development and regulatory milestones
Japan ’s Otsuka Pharma ceutical said on Thursday it agreed to pay more than $1-billion to acquire Jnana Therapeutics as it looks to expand its drug pipeline and research base in the Boston area.
Otsuka is joining domestic rivals Ono Pharma, Takeda Pharmaceutical and Astellas Pharma in making big overseas deals to replenish their drug portfolios. Otsuka will pay $800-million to Jnana shareholders along with up to $325-million in development and regulatory milestones, the Japanese company said in a statement. The deal is expected to be completed in the third quarter of this year.
Jnana is a clinical-stage biotechnology company with drug candidates for rare diseases and immune disorders. Its lead program, JNT-517, is a potential treatment for phenylketonuria , a rare genetic metabolic disease. Otsuka focuses on psychiatric drugs, such as the antipsychotic Abilify, as well as cancer treatments. Its consumer goods division produces the Pocari Sweat electrolyte drink and the Calorie Mate energy bar for the domestic Japanese market.
Otsuka Company Disease Drug Japan Deal Pharma Japan Boston Otsuka
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Viking Therapeutics weight-loss drug moves to Phase 3 trialShares of Viking Therapeutics (VKTX) are soaring after the company announced plans to advance its experimental weight-loss injection — named VK2735 — to a...
Read more »
Eli Lilly loses $120B in value over Viking's GLP-1 progressPharmaceutical giant Eli Lilly (LLY) lost approximately $120 billion in market value this week following an announcement from competitor Viking Therapeutics ...
Read more »
Sainsbury’s Gains Share as Grocer Focuses on Food and PricingJ Sainsbury Plc said its fiscal year is off to a good start with sales rising as more consumers choose the grocer for their weekly food shopping.
Read more »
Exclusive-Icahn-owned oil refiner CVR bidding in Citgo share auction, sources sayOil refiner CVR Energy, controlled by billionaire investor Carl Icahn, has submitted a binding offer in an ongoing auction of shares in the parent of...
Read more »
30 Medical Professionals Share Horror Stories Of Patients Ignoring Their AdviceSomeone asked “Medical professionals, what was a time where a patient ignored you and almost died because of it?” and people shared their most harrowing stories.
Read more »
We Asked People To Share The Best Love And Dating Advice They've Ever ReceivedBrittany Wong is a senior reporter covering lifestyle topics at HuffPost. She is a graduate of UCLA and a native Angeleno. She can be reached at brittany.wonghuffpost.com
Read more »